Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

REal-World Treatment Outcomes of Oral-Anticoagulants Among Patients With Atrial Fibrillation - Patient Survey - RETAF-PS

NCT05471830 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT05471830
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05471830 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
REal-World Treatment Outcomes of Oral-Anticoagulants Among Patients With Atrial Fibrillation - Patient Survey - RETAF-PS
Lead sponsor
Bayer
Phase
Observational
Overall status
Completed
Start date
November 30, 2022
Completion date
December 1, 2023
Enrollment
600 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation, prevention of thromboembolic events